Patents Assigned to pSiMedica Limited
-
Patent number: 9745199Abstract: A method of making mesoporous silicon from silica, the mesoporous silicon obtained by the method, and uses of the mesoporous silicon are described. The mesoporous silicon may be derived from plants, particularly land-based plants.Type: GrantFiled: February 27, 2012Date of Patent: August 29, 2017Assignee: PSIMEDICA LIMITEDInventors: Leigh Trevor Canham, Armando Loni
-
Patent number: 9566235Abstract: In some aspects, the invention relates to a porous implant, comprising a resorbable or bio-erodible porous silicon-based carrier material; a reservoir formed within the body of the porous silicon-based carrier material; and a beneficial substance disposed within the reservoir.Type: GrantFiled: August 18, 2015Date of Patent: February 14, 2017Assignee: pSiMedica LimitedInventors: Leigh T. Canham, Christopher P. Barrett, Timothy I. Cox, Peter J. Wright, Andrew P. Bowditch
-
Patent number: 9540246Abstract: A method of making porous silicon using a chemical etchant comprising metal ions is described.Type: GrantFiled: December 16, 2010Date of Patent: January 10, 2017Assignee: PSIMEDICA LIMITEDInventors: Leigh Trevor Canham, Armando Loni
-
Patent number: 9243144Abstract: A consumer care composition or a food composition comprising a mesoporous microparticulate material wherein at least some of the pores of the material are loaded with at least one ingredient and the loaded mesoporous microparticulate material is encapsulated by a capping layer is described.Type: GrantFiled: September 30, 2009Date of Patent: January 26, 2016Assignee: PSIMEDICA LIMITEDInventors: Leigh Canham, Qurrat Ul Ain Shabir, Armando Loni
-
Patent number: 9205051Abstract: A porous silicon implant impregnated with a beneficial substance, such as a micromineral required for healthy physiology, is implanted subcutaneously and is entirely corroded away over the following months/year to release the beneficial substance in a controlled manner. In a second embodiment the implant may have a large number of holes which contain beneficial substance and which are closed by bio-erodible doors of different thickness so as to stagger the release of the beneficial substance over time as the doors are breached.Type: GrantFiled: December 4, 2013Date of Patent: December 8, 2015Assignee: pSiMedica Limited, Inc.Inventors: Leigh T. Canham, Christopher P. Barrett, Timothy I. Cox, Peter J. Wright, Andrew P. Bowditch
-
Publication number: 20140079930Abstract: A method of making mesoporous silicon from silica, the mesoporous silicon obtained by the method, and uses of the mesoporous silicon are described. The mesoporous silicon may be derived from plants, particularly land-based plants.Type: ApplicationFiled: February 27, 2012Publication date: March 20, 2014Applicant: PSIMEDICA LIMITEDInventors: Leigh Trevor Canham, Armando Loni
-
Patent number: 8623399Abstract: A porous silicon implant impregnated with a beneficial substance, such as a micromineral required for healthy physiology, is implanted subcutaneously and is entirely corroded away over the following months/year to release the micromineral in a controlled manner. In a second embodiment the implant may have a large number of holes which contain beneficial substance and which are closed by bio-erodible doors of different thickness so as to stagger the release of the beneficial substance over time as the doors are breached.Type: GrantFiled: September 12, 2012Date of Patent: January 7, 2014Assignee: pSiMedica LimitedInventors: Leigh T. Canham, Christopher P. Barrett, Timothy I. Cox, Peter J. Wright, Andrew P. Bowditch
-
Publication number: 20130064965Abstract: A porous silicon implant impregnated with a beneficial substance, such as a micromineral required for healthy physiology, is implanted subcutaneously and is entirely corroded away over the following months/year to release the micromineral in a controlled manner. In a second embodiment the implant may have a large number of holes which contain beneficial substance and which are closed by bio-erodible doors of different thickness so as to stagger the release of the beneficial substance over time as the doors are breached.Type: ApplicationFiled: September 12, 2012Publication date: March 14, 2013Applicant: PSIMedica LimitedInventors: Leigh T. Canham, Christopher P. Barrett, Timothy I. Cox, Peter J. Wright, Andrew P. Bowditch
-
Patent number: 8361491Abstract: A porous silicon implant impregnated with a beneficial substance, such as a micromineral required for healthy physiology, is implanted subcutaneously and is entirely corroded away over the following months/year to release the micromineral in a controlled manner. In a second embodiment the implant may have a large number of holes which contain beneficial substance and which are closed by bio-errordable doors of different thickness so as to stagger the release of the beneficial substance over time as the doors are breached.Type: GrantFiled: April 4, 2011Date of Patent: January 29, 2013Assignee: PSIMedica LimitedInventors: Leigh T. Canham, Christopher P. Barrett, Timothy I. Cox, Peter J. Wright, Andrew P. Bowditch
-
Patent number: 8318194Abstract: A porous silicon implant impregnated with a beneficial substance, such as a micromineral required for healthy physiology, is implanted subcutaneously and is entirely corroded away over the following months/year to release the micromineral in a controlled manner. In a second embodiment the implant may have a large number of holes which contain beneficial substance and which are closed by bio-errordable doors of different thickness so as to stagger the release of the beneficial substance over time as the doors are breached.Type: GrantFiled: June 28, 2010Date of Patent: November 27, 2012Assignee: PSIMedica LimitedInventors: Leigh T. Canham, Christopher P. Barrett, Andrew P. Bowditch, Timothy I. Cox, Peter J. Wright
-
Patent number: 8313761Abstract: A porous silicon implant impregnated with a beneficial substance, such as a micromineral required for healthy physiology, is implanted subcutaneously and is entirely corroded away over the following months/year to release the micromineral in a controlled manner. In a second embodiment the implant may have a large number of holes which contain beneficial substance and which are closed by bio-errordable doors of different thickness so as to stagger the release of the beneficial substance over time as the doors are breached.Type: GrantFiled: April 4, 2011Date of Patent: November 20, 2012Assignee: PSIMedica LimitedInventors: Leigh T. Canham, Christopher P. Barrett, Timothy I. Cox, Peter J. Wright, Andrew P. Bowditch
-
Patent number: 8303975Abstract: A porous silicon implant impregnated with a beneficial substance, such as a micromineral required for healthy physiology, is implanted subcutaneously and is entirely corroded away over the following months/year to release the micromineral in a controlled manner. In a second embodiment the implant may have a large number of holes which contain beneficial substance and which are closed by bio-errordable doors of different thickness so as to stagger the release of the beneficial substance over time as the doors are breached.Type: GrantFiled: August 19, 2010Date of Patent: November 6, 2012Assignee: PSIMedica LimitedInventors: Leigh T Canham, Christopher P Barrett, Timothy I Cox, Peter J Wright, Andrew P Bowditch
-
Patent number: 8293630Abstract: The present invention concerns new methods of fabricating a silicon material comprising phosphorus. The methods allow high levels of phosphorus to be combined with the silicon. In one aspect of the invention a sample of phosphorus is surrounded with a sample of silicon. At least some of the phosphorus is then vaporised and caused to interact with the silicon.Type: GrantFiled: December 15, 2004Date of Patent: October 23, 2012Assignee: Psimedica LimitedInventors: John Joseph Dunkley, Brett Telford, Stephen Edward Connor
-
Publication number: 20120134917Abstract: Dermatological methods of cosmetic, therapeutic, prophylactic, and/or diagnostic treatment by topically applying compositions comprising a multiplicity of particles, at least one of the particles comprising porous and/or polycrystalline silicon. Included are methods and compositions for sun protection applications. The use of porous silicon, polycrystalline silicon, and porous silicon oxide mirrors is disclosed.Type: ApplicationFiled: January 27, 2012Publication date: May 31, 2012Applicant: pSiMedica LimitedInventors: Leigh T. Canham, Roger Aston
-
Publication number: 20120076723Abstract: The invention relates to the treatment of cancer. In particular the invention relates to an internal therapeutic product comprising: (i) an anti-cancer component selected from one or both of: a radionucleotide, a cytotoxic drug; and (ii) a silicon component selected from one or more of: resorbable silicon, biocompatible silicon, bioactive silicon, porous silicon, polycrystalline silicon, amorphous silicon, and bulk crystalline silicon, the internal therapeutic product being for the treatment of cancer.Type: ApplicationFiled: December 8, 2011Publication date: March 29, 2012Applicant: pSiMedica LimitedInventors: Roger ASTON, Leigh T. Canham
-
Method of protecting skin from UV radiation using a dermatological composition having porous silicon
Patent number: 8128912Abstract: Dermatological methods of cosmetic, therapeutic, prophylactic, and/or diagnostic treatment by topically applying compositions comprising a multiplicity of particles, at least one of the particles comprising porous and/or polycrystalline silicon. Included are methods and compositions for sun protection applications. The use of porous silicon, polycrystalline silicon, and porous silicon oxide mirrors is disclosed.Type: GrantFiled: June 2, 2005Date of Patent: March 6, 2012Assignee: pSIMEDICA LimitedInventors: Leigh T Canham, Roger Aston -
Patent number: 8097236Abstract: The invention relates to the treatment of cancer. In particular the invention relates to an internal therapeutic product comprising: (i) an anti-cancer component selected from one or both of: a radionucleotide, a cytotoxic drug; and (ii) a silicon component selected from one or more of: resorbable silicon, biocompatible silicon, bioactive silicon, porous silicon, polycrystalline silicon, amorphous silicon, and bulk crystalline silicon, the internal therapeutic product being for the treatment of cancer.Type: GrantFiled: February 20, 2002Date of Patent: January 17, 2012Assignee: pSiMedica LimitedInventors: Roger Aston, Leigh T Canham
-
Patent number: 8088401Abstract: The invention provides a composite material comprising a porous semiconductor impregnated with at least one beneficial organic substance, wherein the beneficial organic substance is present in an amount of at least 15% by weight, based on the weight of the material. Also provided are methods for the preparation of such materials, pharmaceutical compositions comprising them and their use in methods of treatment.Type: GrantFiled: October 21, 2004Date of Patent: January 3, 2012Assignee: Psimedica LimitedInventors: Roghieh Saffie, Leigh Canham
-
Publication number: 20110217354Abstract: A porous silicon implant impregnated with a beneficial substance, such as a micromineral required for healthy physiology, is implanted subcutaneously and is entirely corroded away over the following months/year to release the micromineral in a controlled manner. In a second embodiment the implant may have a large number of holes which contain beneficial substance and which are closed by bio-errordable doors of different thickness so as to stagger the release of the beneficial substance over time as the doors are breached.Type: ApplicationFiled: April 4, 2011Publication date: September 8, 2011Applicant: PSIMedica LimitedInventors: Leigh T. Canham, Christopher P. Barrett, Timothy I. Cox, Peter J. Wright, Andrew P. Bowditch
-
Publication number: 20110217353Abstract: A porous silicon implant impregnated with a beneficial substance, such as a micromineral required for healthy physiology, is implanted subcutaneously and is entirely corroded away over the following months/year to release the micromineral in a controlled manner. In a second embodiment the implant may have a large number of holes which contain beneficial substance and which are closed by bio-errordable doors of different thickness so as to stagger the release of the beneficial substance over time as the doors are breached.Type: ApplicationFiled: April 4, 2011Publication date: September 8, 2011Applicant: PSIMedica LimitedInventors: Leigh T. Canham, Christopher P. Barrett, Timothy I. Cox, Peter J. Wright, Andrew P. Bowditch